Ziren Kong
机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center · ORCID：0000-0001-6588-4757
发表论文 101 篇 · 总被引 1343 次 · h-index 21
代表论文
- Porphyrin-Engineered 125 I-Nanoseeds as a Prototype for Immunogenic Brachytherapy (2025 · Journal of the American Chemical Society · 被引 8)
- Covalent FAPI Imaging–Guided Precision Surgery in Patients with Medullary Thyroid Carcinoma: A Phase II Clinical Trial (2026 · Clinical Cancer Research · 被引 1)
- Publisher Correction: Covalent targeted radioligands potentiate radionuclide therapy (2025 · Nature · 被引 1)
- Supplementary Table 14 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma (2026)
- Supplementary Table 9 from CTR-FAPI PET Enables Precision Management of Medullary Thyroid Carcinoma (2026)
- Data from Covalent FAPI Imaging–Guided Precision Surgery in Patients with Medullary Thyroid Carcinoma: A Phase II Clinical Trial (2026)